Signaling Pathways - MAGL - G9a - p70 rsk - Insulin and Insulin-like Receptors
清除全部
- B5815 LY2584702Target: p70 rskSummary: P70 S6激酶抑制剂
- B7757 UNC 0642Target: G9a|GLPSummary: G9a和GLP组蛋白赖氨酸甲基转移酶抑制剂
- B2228 PF-47086711 CitationTarget: p70 rskSummary: P70 S6K1亚型抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A5653 AT7867Target: Akt|PKA|p70 rskSummary: Akt1/2/3和p70S6K/PKA的抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂
- A1909 BIX 01294Target: G9aSummary: G9a和GLP抑制剂